Mendus Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference in September

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Mendus Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference in September
 8:00:00 AM

Keep reading
Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia (AML)Read